Acknowledgement
본 연구는 한국보건산업진흥원 한의약혁신기술개발 사업의 위암 한의표준임상진료지침 및 한의표준임상경로 개발 과제(과제번호:HF20C0204), 폐암 한의통합암치료의 한의임상진료지침 및 한의표준임상경로 개발 과제(과제번호:HF23C0093)와 2022학년도 부산대학교 신임교수연구 정착금 지원으로 이루어졌습니다.
References
- 2020 Cancer Registry Statistics and 2014-2018 Regional Cancer Incidence Statistics press release. 2022. National Cancer Center(https://ncc.re.kr)
- National Cancer Information Center. Cancer Information Service Website [Internet]. 2021[updated 2021 Dec 30; cited 2022 JUL 6]. Available From: https://www.cancer.go.kr/lay1/S1T639C641/contents.do.
- National Cancer Institute (https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neoplasm)
- National Cancer Information Center. Gastric Cancer. 2020.
- National University of Korean Medicine Department of Internal Medicine. Department of Internal Medicine, Seoul:Goonja Publishers; 2016; 350-65.
- Hwang SY, Ahn SH, Keum KS. Proposal on Spplementation to Oriental Medical Policy for the Revitalization of Oriental Medical Therapy for Stomach Cancer. Journal of Physiology & Pathology in Korean Medicine. 2009;23(3):528-33.
- Mok Yeong-Jae. "Diagnosis and Treatment of Stomach Cancer." Proceedings of the Korean Society of Radiological Science 2002; 06a:12-16.
- Kim DS. Current status and tasks of the development of Korean Medicine clinical practice guideline. J Kor Med policy. 2017;5(1):20-8.
- National Cancer Information Center, Cancer in statistics [Internet]. 2021[updated 2021 Dec 30; cited 2022 JUL 6]. Available From: https://www.cancer.go.kr/main2.do.
- National Cancer Information Center. Cancer Information Service Website [Internet]. 2021[updated 2021 Dec 30; cited 2022 JUL 6]. Available From: https://www.cancer.go.kr/lay1/S1T639C641/contents.do.
- Lee SH, Kim MC, Jeon SW, Lee KN, Park JJ, Hong SJ. Risk factors and clinical outcomes of non-curative resection in patients with early gastric cancer treated with endoscopic submucosal dissection: a retrospective multicenter study in Korea. Clin Endosc 2020;53:196-205. https://doi.org/10.5946/ce.2019.123
- Park JM. Quality indicator for gastric cancer detection based on Helicobacter pylori status. Clin Endosc 2020;53:629-30. https://doi.org/10.5946/ce.2020.270
- Choi YJ, Lee JS, & Cho SH. Use of Korean Medicine among Cancer Patients. J Korean Oriental Med, 2012;33(3):46-53. https://doi.org/10.3341/jkos.2012.53.4.559
- Jung JH, Seo JC, Kwak MA, Sohn KC. Literature Review on Traditional Chinese Medicine Treatment of Gastric Cancer. J Int Korean Med 2014;35(3):332-42.
- Han GJ, Seong S, Kim SS, et al. "Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for gastric cancer]." J Korean Med. 2017;38(3):124-42. https://doi.org/10.13048/jkm.17031
- Kim HR, Yoo HS, Baek DG, et al. "Clinical Practice Guidelines in Korean Medicine for Gastric Cancer." J. Int. Korean Med. 2016;37(1):26-46.
- Jeong TY, Lee YW, Cho CK, Yoo HS. Analysis of Clinical Characteristics for 899 Cancer Patients Treatedatan Oriental Hospital. Korean J. Orient. Int. Med. 2010;31(1):102-12.
- Ha EJ, Park HJ. The Effect Gastrointestinal Symptoms, Distress, and Cancer Coping on Quality of Life of Gastric Cancer Patients with Gastrectomy. Journal of the Korea Academia-Industrial cooperation Society, 2023;24(2):373-81. https://doi.org/10.5762/KAIS.2023.24.2.373